These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24588596)

  • 21. Lipid-based nanocarriers for breast cancer treatment - comprehensive review.
    Talluri SV; Kuppusamy G; Karri VV; Tummala S; Madhunapantula SV
    Drug Deliv; 2016 May; 23(4):1291-305. PubMed ID: 26430913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.
    Hunter AC; Elsom J; Wibroe PP; Moghimi SM
    Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer chemotherapy with lipid-based nanocarriers.
    Liu D; Zhang N
    Crit Rev Ther Drug Carrier Syst; 2010; 27(5):371-417. PubMed ID: 21083528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.
    Souto EB; Müller RH
    Handb Exp Pharmacol; 2010; (197):115-41. PubMed ID: 20217528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Advances in Ocular Drug Delivery, with Special Emphasis on Lipid Based Nanocarriers.
    Sah AK; Suresh PK
    Recent Pat Nanotechnol; 2015; 9(2):94-105. PubMed ID: 27009124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipids and their derivatives: by-products used as essential building blocks for modern drug delivery systems.
    Tu Y; Zhu L
    Curr Drug Targets; 2014 May; 15(5):502-17. PubMed ID: 24597533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanocarriers for the Effective Treatment of Cervical Cancer: Research Advancements and Patent Analysis.
    Pathak K; Akhtar N
    Recent Pat Drug Deliv Formul; 2018; 12(2):93-109. PubMed ID: 29611489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent Patents on Polymeric Nanoparticles for Cancer Therapy.
    Pandey P; Dureja H
    Recent Pat Nanotechnol; 2018; 12(2):155-169. PubMed ID: 29589551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanotechnology applied to the treatment of malaria.
    Santos-Magalhães NS; Mosqueira VC
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):560-75. PubMed ID: 19914313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patents on nanoparticulate drug delivery systems--a review.
    Bhavna ; Ali M; Baboota S; Ali J
    Recent Pat Drug Deliv Formul; 2008; 2(1):83-9. PubMed ID: 19075900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent Trends in Nanotechnology-Based Drugs and Formulations for Targeted Therapeutic Delivery.
    Iqbal HMN; Rodriguez AMV; Khandia R; Munjal A; Dhama K
    Recent Pat Inflamm Allergy Drug Discov; 2017; 10(2):86-93. PubMed ID: 27978790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active Targeting of Drugs and Bioactive Molecules via Oral Administration by Ligand-Conjugated Lipidic Nanocarriers: Recent Advances.
    Shreya AB; Raut SY; Managuli RS; Udupa N; Mutalik S
    AAPS PharmSciTech; 2018 Dec; 20(1):15. PubMed ID: 30564942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nanometer lipid emulsion, lipid nano-sphere (LNS), as a parenteral drug carrier for passive drug targeting.
    Seki J; Sonoke S; Saheki A; Fukui H; Sasaki H; Mayumi T
    Int J Pharm; 2004 Apr; 273(1-2):75-83. PubMed ID: 15010132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folate-targeting magnetic core-shell nanocarriers for selective drug release and imaging.
    Wang H; Wang S; Liao Z; Zhao P; Su W; Niu R; Chang J
    Int J Pharm; 2012 Jul; 430(1-2):342-9. PubMed ID: 22525087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleoside-lipid-based nanoparticles for cisplatin delivery.
    Khiati S; Luvino D; Oumzil K; Chauffert B; Camplo M; Barthélémy P
    ACS Nano; 2011 Nov; 5(11):8649-55. PubMed ID: 21961944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
    Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
    Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanocarriers as Tools in Delivering Active Compounds for Immune System Related Pathologies.
    Soica C; Coricovac D; Dehelean C; Pinzaru I; Mioc M; Danciu C; Fulias A; Puiu M; Sitaru C
    Recent Pat Nanotechnol; 2016; 10(2):128-45. PubMed ID: 27502390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid-enveloped hybrid nanoparticles for drug delivery.
    Tan S; Li X; Guo Y; Zhang Z
    Nanoscale; 2013 Feb; 5(3):860-72. PubMed ID: 23292080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting.
    Gupta U; Jain NK
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):478-90. PubMed ID: 19913579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.